Editorial: Identifying Neuroimaging-Based Markers for Distinguishing Brain Disorders

Editorial: Biology of Brain Disorders

Development of multimodal neuroimaging markers for neurological disorders - Part 2.

The second part of the special issue includes 5 articles. Among them, two evaluate the treatment effect using imaging techniques including fMRI and optical positioning system (OPS), and three address the issues related to development and application of new methods for improving the accuracy and efficiency of neuroimaging data analysis. Tumour tracking and radiotherapy are the most implemented t...

Development of multimodal neuroimaging markers for neurological disorders - Part 1.

Multi-modal neuroimaging, including electroencephalography (EEG), magnetoencephalography (MEG), positron emission tomography (PET), magnetic resonance imaging (MRI), Near-infrared spectroscopy (NIRS), and single-photon emission computed tomography (SPECT), have been widely used in the diagnosis of neurological diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and multiple sc...

P28: Neuroimaging in Anxiety Disorders

In recent years, the development of neuroimaging techniques such as high-resolution magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), positron emission tomography (PET), or single photon emission tomography (SPECT) has promoted the identification of structural and functional characteristics underlying mental disorders to a great extent. In anxiety disorders, recent...

Editorial: Neuroimaging in dementias

Advances in different neuroimaging modalities such as structural and functional Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET), (including FDG-PET and recent amyloid/tau tracers) have changed the role of neuroimaging in the diagnosis of dementias. Instead of only excluding other secondary diagnoses, neuroimaging has become a potential biomarker that evaluates the pathop...